Schmidt Eric Thomas
CIK 0001754403
Chief Financial OfficerDirector
Filings
8
Latest Jun 12, 2023
Issuers covered
3
Showing
8 of 8
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -5.8% | -5.8% | -5.8% | -5.8% |
| 90 days | 1 | 0% | -13.5% | -13.5% | -13.5% | -13.5% |
| 180 days | 1 | 0% | -85.9% | -85.9% | -85.9% | -85.9% |
| 365 days | 1 | 100% | +27.4% | +27.4% | +27.4% | +27.4% |
Issuers
Companies where Schmidt Eric Thomas has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | 4 | Mar 24, 2023 |
| RLMD | Relmada Therapeutics, Inc. | 2 | May 30, 2023 |
| RVMD | Revolution Medicines, Inc. | 2 | Jun 12, 2023 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|